Cargando…

The kinetics of SARS-CoV-2 viremia in COVID-19 patients receiving remdesivir

Detection of SARS-CoV-2 RNA in serum, viremia, has been linked to disease severity and outcome. The kinetics of viremia in patients receiving remdesivir has not been thoroughly studied and could help predict treatment response and outcome. We investigated the kinetics of SARS-CoV-2 viremia and facto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krifors, Anders, Karlsson, Linda, Ekman, Martin, Lorant, Camilla, Skorup, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224642/ https://www.ncbi.nlm.nih.gov/pubmed/37243828 http://dx.doi.org/10.1007/s10096-023-04627-4

Ejemplares similares

Early experience with remdesivir in SARS-CoV-2 pneumonia
por: Durante-Mangoni, Emanuele, et al.
Publicado: (2020)

Contre Sars-CoV-2, brequinar ou remdesivir ?
por: Manus, Jean-Marie
Publicado: (2021)

Remdesivir therapy associated with Bradycardia in SARS‐CoV2
por: Kumar, Sabina, et al.
Publicado: (2021)

Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
por: Kokic, Goran, et al.
Publicado: (2021)

Enhanced Remdesivir Analogues to Target SARS-CoV-2
por: Majima, Ryuichi, et al.
Publicado: (2023)

Increased Prevalence of Myocardial Injury in Patients with SARS-CoV-2 Viremia
por: Siddiqi, Hasan K., et al.
Publicado: (2021)

Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection
por: Vulturar, Damiana-Maria, et al.
Publicado: (2022)

Pre-exposure to mechanical ventilation and endotoxemia increases Pseudomonas aeruginosa growth in lung tissue during experimental porcine pneumonia
por: Sperber, Jesper, et al.
Publicado: (2020)

Arguments in favour of remdesivir for treating SARS-CoV-2 infections
por: Ko, Wen-Chien, et al.
Publicado: (2020)

Remdesivir in kidney transplant patients with SARS-CoV-2 pneumonia()
por: Cacho, Judit, et al.
Publicado: (2022)

Low-level SARS-CoV-2 viremia coincident with COVID placentitis and stillbirth
por: Mithal, Leena B., et al.
Publicado: (2022)

No findings of SARS-CoV-2 in conjunctival swabs from patients at an emergency outpatient ophthalmological healthcare facility in a Swedish county hospital: a cross-sectional study
por: Granstam, Elisabet, et al.
Publicado: (2021)

Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
por: Pruijssers, Andrea J., et al.
Publicado: (2020)

Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2
por: Dobrovolny, Hana M.
Publicado: (2020)

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
por: Williamson, Brandi N., et al.
Publicado: (2020)

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
por: Williamson, Brandi N., et al.
Publicado: (2020)

Remdesivir, la esperanza antiviral frente al SARS-CoV-2
por: Reina, Jordi
Publicado: (2020)

Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir
por: Lo, Ho Sing, et al.
Publicado: (2021)

Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
por: Yoon, Jin Gu, et al.
Publicado: (2022)

Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication
por: Bravo, Jack P.K., et al.
Publicado: (2021)

The strand-biased transcription of SARS-CoV-2 and unbalanced inhibition by remdesivir
por: Zhao, Yan, et al.
Publicado: (2021)

Liver and Renal Injury with Remdesivir Treatment in SARS-CoV-2 Patients
por: Sadaf, Rabiah, et al.
Publicado: (2023)

Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir
por: Negru, Paul Andrei, et al.
Publicado: (2022)

SARS-CoV-2 viremia may predict rapid deterioration of COVID-19 patients
por: Tan, Cuiyan, et al.
Publicado: (2020)

SARS-CoV-2 viremia and COVID-19 mortality: A prospective observational study
por: Giacomelli, Andrea, et al.
Publicado: (2023)

Computational and theoretical exploration for clinical suitability of Remdesivir drug to SARS-CoV-2
por: Nayeem, Shaik Mahammad, et al.
Publicado: (2021)

Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
por: Choy, Ka-Tim, et al.
Publicado: (2020)

Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir
por: Chen, Ting, et al.
Publicado: (2021)

Remdesivir overcomes the S861 roadblock in SARS-CoV-2 polymerase elongation complex
por: Wu, Jiqin, et al.
Publicado: (2021)

Hybrid physiologically‐based pharmacokinetic model for remdesivir: Application to SARS‐CoV‐2
por: Gallo, James M.
Publicado: (2021)

In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2
por: Szemiel, Agnieszka M., et al.
Publicado: (2021)

Efficacy and Safety of Remdesivir over Two Waves of the SARS-CoV-2 Pandemic
por: Poliseno, Mariacristina, et al.
Publicado: (2021)

487. Experience with Remdesivir for Treatment of SARS-CoV-2 in Patients with Liver Cirrhosis
por: Saunders-Hao, Patricia, et al.
Publicado: (2021)

Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir
por: Moreno, Santiago, et al.
Publicado: (2022)

Use of remdesivir in kidney transplant recipients with SARS-CoV-2 Omicron infection
por: Cacho, Judit, et al.
Publicado: (2022)

Remdesivir-induced emergence of SARS-CoV2 variants in patients with prolonged infection
por: Heyer, Andreas, et al.
Publicado: (2022)

SARS‐CoV‐2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID‐19
por: Myhre, Peder L., et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 Viremia in Presymptomatic Blood Donors in the Delta and Omicron Variant Eras
por: Saá, Paula, et al.
Publicado: (2023)

Combination Therapy With Casirivimab/Imdevimab and Remdesivir for Protracted SARS-CoV-2 Infection in B-cell-Depleted Patients
por: Dioverti, M Veronica, et al.
Publicado: (2022)

A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
por: Simonis, Alexander, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tuciuoep8ks1bahh8ej758dp6q